Ann Marie Kimball

Last updated
Ann Marie Kimball
NationalityAmerican
Alma mater Stanford University
University of Washington School of Medicine
Occupation(s)Epidemiologist, physician,
AwardsFellow, American College of Preventive Medicine
Fulbright New Century Scholar Award
Guggenheim Scholar award
In Resident scholar, Bellagio Center (Rockefeller)
HHS Secretary Outstanding Team Award, Department of Health, Washington State
Scientific career
Institutions University of Washington
Chatham House Royal Institute of Foreign Affairs

Ann Marie Kimball is an American physician. She is known for being the pioneer of electronic disease surveillance for infectious disease outbreaks and pandemics. She is currently a Professor Emerita in the Department of Epidemiology at the University of Washington, [1] a Consulting Fellow at the Chatham House Royal Institute of Foreign Affairs, [2] and was a Strategic Consultant in Global Health at the Rockefeller Foundation. Kimball served as a technical and strategic lead for the Bill and Melinda Gates Foundation infectious disease surveillance strategy formation.

Contents

Kimball's research on global trade and emerging infections has earned her a Fulbright New Century Scholars award and a Guggenheim Scholars award. She is the author of two books, entitled Risky Trade: Infectious Diseases in an Era of Global Trade, and Risks and Challenges in Medical Tourism. [3] She has also done extensive media work with television, radio and the press. [4] Kimball brought important innovations to international infectious disease surveillance through the founding of the APEC Emerging Infections network advanced electronic disease surveillance and networking in the Asia Pacific. [2]

Kimball is a Fellow in the American College of Preventive Medicine.

Education

Kimball obtained a bachelor's degree from Stanford University with honors in Humanities and Biology in 1972. She then enrolled at the University of Washington School of Medicine and earned a Doctor of Medicine degree with thesis honors in 1976, and a Master of Public Health degree in 1981. Kimball did Internship and Residency training in Internal Medicine at the University of Washington. and completed a Preventive Medicine residency at the Centers for Disease Control, Atlanta and the University of Washington, Seattle. [1]

Career

Following her Internal Medicine Internship at the University of Washington, Kimball started her career as and EIS officer at the Centers for Disease Control concurrently serving as an instructor in the Department of Medicine at Emory University in 1977 and served there till 1979. She was key in the investigation of infant cholera in Bahrain, the results of which contributed to the ban on infant formula marketing to developing countries. [5] She served as Emergency Room Physician at Northgate General Hospital, Seattle, from 1979 till 1981. As an Attending Physician, she held appointments at HMC/Madison Clinic for HIV from 1991 till 1996, at HMC International Clinic from 1997 till 2002, and at Harborview Medical Center (HMC) Sexually Transmitted Disease Clinic from 2002 till 2011. From 1991 to 2011, she was associated with Harborview Medical Center Medical Staff, and also served as Volunteer Physician at Walker-Whitman Clinic, Incorporated for a year. [1]

While at the Centers for Disease Control, She held a brief appointment as a lecturer at American University of Beirut, Lebanon. Recruited as deputy director for the SHDS based in Abidjan, Côte d'Ivoire, (Strengthening Health Delivery Systems in West and Central Africa) she concurrently joined Boston University School of Public Health as a Clinical Assistant Professor in 1981. From 1983 to 1985, Kimball served as Research Advisor to the MCH Division of the Ministry of Health, Sanaa Yemen and Oil Rig physician for Yemen Hunt Oil, and Air France while residing in Sanaa. Kimball was then recruited to serve as Regional Advisor for Columbia University's USAID funded program in Operations Research in Family Planning based in Dakar, Senegal. From 1985 to 1990, she was appointed as an Assistant Professor of Clinical Public Health at Columbia University. In 1988 she returned to the US as Regional Advisor for HIV/AIDS and head of National Program Support with the Pan American Health Organization based in Washington DC. Returning to Washington State in 1991 as Director of the Division of HIV/AIDS with the Department of Health, Washington State she joined the University of Washington as a Clinical Assistant Professor of Medicine and Epidemiology. Concurrently she was elected as Chair of the nascent National Alliance of State and Territorial AIDS Directors (NASTAD). She joined U.W. faculty full time and became Associate Professor of Health Services & Epidemiology as well as Adjunct in Medicine in 1993, an Adjunct in Medicine and Biomedical and Health Informatics in 2001, and an Adjunct in International Studies at Jackson School of International Studies in 2009. Promoted to Professor of Epidemiology and Health Services in 2001, she retired in 2011, becoming Professor Emerita in the Department of Epidemiology at the University of Washington. [1]

In 2012, Kimball was recruited as Senior Program Officer to the Bill and Melinda Gates Foundation for Epidemiology and Surveillance with the Global Health program. Retiring in 2015 she joined Chatham House as an associate fellow, leading a Rockefeller funded initiative to strengthen post-ebola surveillance in West Africa. She was promoted to Senior Consulting Fellow in 2017.

A Rotarian for 25 years, Kimball serves as vice-chair of the Rotary International/ Rotary Foundation COVID-19 Task Force. This group guides Rotary's response to the pandemic. [6]

Works

During the early days of the Internet Kimball founded the APEC Emerging Infections Network in 1996, [7] and led research and training programs in Surveillance and Informatics in Peru and Thailand.

In 2003 after supporting APEC/EINET, APEC formed a Health Task force which was formalized into a standing working group in 2007. [8] Heading the National Alliance and the AIDS effort in Washington State, Kimball promoted the critical role local and state public health entities through the "AIDSNET" organization in Washington State.

As the HIV/AIDS pandemic reached the Asia Pacific Kimball advocated for public private partnerships to strengthen the weak public sector capacity in the region. She founded the Asia Pacific Alliance Against AIDS at the Yokohama global HIV/AIDS Conference, forerunner to the Global Business Council on AIDS founded in 1997.

Recruited to the Bill and Melinda Gates Foundation in 2012, Kimball led the development of a foundation wide infectious disease surveillance strategy which was presented and adopted in 2015. Concurrently she negotiated the development of "Menafrinet" a surveillance system for Meningitis across West and Central Africa co-led by national authorities, CDC USA and Medecins Preventif of France. [9]

In her policy studies regarding novel human infections, Kimball has also discussed new challenges and health security against pandemic threats. [10] Since 2015, she has served as a Senior Consulting Fellow for Chatham House, London. In 2019, she introduced Innovative fellowship program based on the strengthening of public health leadership in Africa. Her research indicated that Ebola virus disease crisis in West Africa revealed critical weaknesses in health policy and systems in the region, and emphasized the significance of innovative models in terms of enhancing the capabilities of emerging leaders. [11] She also conducted a study in Peru in 2007, highlighting the role of internet as a tool to approach high-risk men who have sex with men. [12] In her studies, she also discussed quantitative measurements regarding the impacts of epidemic disease ‘cholera’ on international trade particularly in Mozambique, Kenya, Tanzania and Uganda in 1997. [13]

In her research regarding COVID-19 and Spanish flu, [14] [15] Kimball stated that "The coronavirus mutates at a slower pace than flu viruses, making it a more stable target for vaccination." [16] Furthermore, she focused on acquiring the immunity in order to survive the infection. [17]

In 2006, Kimball published a book Risky Trade: Infectious Disease in the Era of Global Trade. [18] Nitsan Chorev discussed the book as an "interplay between globalization, trade and travel, and infectious diseases." [19] Núria Torner states that the "book raised interesting questions on infectious diseases and offered new insights into what future challenges may face mankind" and also discussed how it gives a reader "a thorough insight into how our "modern" civilisation, with its so‐called globalisation trends, has upset the balance between natural barriers and infection spread." [20] Andrew Price-Smith reviewed that the author of the book "provides an excellent critique of health governance at the domestic level within the United States." [21]

Awards and honors

Bibliography

Books

Selected articles

Related Research Articles

<span class="mw-page-title-main">Pandemic</span> Global epidemic of infectious disease

A pandemic is an epidemic of an infectious disease that has spread across a large region, for instance multiple continents or worldwide, affecting a substantial number of individuals. Widespread endemic diseases with a stable number of infected individuals such as recurrences of seasonal influenza are generally excluded as they occur simultaneously in large regions of the globe rather than being spread worldwide.

<span class="mw-page-title-main">Zoonosis</span> Disease that can be transmitted from other species to humans

A zoonosis or zoonotic disease is an infectious disease of humans caused by a pathogen that can jump from a non-human to a human and vice versa.

James (Jim) Chin is a public health epidemiologist. He works in public health surveillance and prevention of communicable diseases, particularly AIDS.

<span class="mw-page-title-main">Epidemiology of HIV/AIDS</span> Epidemic of HIV/AIDS

The global epidemic of HIV/AIDS began in 1981, and is an ongoing worldwide public health issue. According to the World Health Organization (WHO), as of 2021, HIV/AIDS has killed approximately 40.1 million people, and approximately 38.4 million people are infected with HIV globally. Of these 38.4 million people, 75% are receiving antiretroviral treatment. There were about 770,000 deaths from HIV/AIDS in 2018, and 650,000 deaths in 2021. The 2015 Global Burden of Disease Study estimated that the global incidence of HIV infection peaked in 1997 at 3.3 million per year. Global incidence fell rapidly from 1997 to 2005, to about 2.6 million per year. Incidence of HIV has continued to fall, decreasing by 23% from 2010 to 2020, with progress dominated by decreases in Eastern Africa and Southern Africa. As of 2020, there are approximately 1.5 million new infections of HIV per year globally.

A syndemic or synergistic epidemic is the aggregation of two or more concurrent or sequential epidemics or disease clusters in a population with biological interactions, which exacerbate the prognosis and burden of disease. The term was developed by Merrill Singer in the early 1990s to call attention to the synergistic nature of the health and social problems facing the poor and underserved. Syndemics develop under health disparity, caused by poverty, stress, or structural violence and are studied by epidemiologists and medical anthropologists concerned with public health, community health and the effects of social conditions on health.

An emergent virus is a virus that is either newly appeared, notably increasing in incidence/geographic range or has the potential to increase in the near future. Emergent viruses are a leading cause of emerging infectious diseases and raise public health challenges globally, given their potential to cause outbreaks of disease which can lead to epidemics and pandemics. As well as causing disease, emergent viruses can also have severe economic implications. Recent examples include the SARS-related coronaviruses, which have caused the 2002-2004 outbreak of SARS (SARS-CoV-1) and the 2019–21 pandemic of COVID-19 (SARS-CoV-2). Other examples include the human immunodeficiency virus which causes HIV/AIDS; the viruses responsible for Ebola; the H5N1 influenza virus responsible for avian flu; and H1N1/09, which caused the 2009 swine flu pandemic. Viral emergence in humans is often a consequence of zoonosis, which involves a cross-species jump of a viral disease into humans from other animals. As zoonotic viruses exist in animal reservoirs, they are much more difficult to eradicate and can therefore establish persistent infections in human populations.

<span class="mw-page-title-main">Disease surveillance</span> Monitoring spread of disease to establish patterns of progression

Disease surveillance is an epidemiological practice by which the spread of disease is monitored in order to establish patterns of progression. The main role of disease surveillance is to predict, observe, and minimize the harm caused by outbreak, epidemic, and pandemic situations, as well as increase knowledge about which factors contribute to such circumstances. A key part of modern disease surveillance is the practice of disease case reporting.

<span class="mw-page-title-main">HIV/AIDS</span> Spectrum of conditions caused by HIV infection

Human immunodeficiency virus infection and acquired immunodeficiency syndrome (HIV/AIDS) is a spectrum of conditions caused by infection with the human immunodeficiency virus (HIV), a retrovirus. Following initial infection an individual may not notice any symptoms, or may experience a brief period of influenza-like illness. Typically, this is followed by a prolonged incubation period with no symptoms. If the infection progresses, it interferes more with the immune system, increasing the risk of developing common infections such as tuberculosis, as well as other opportunistic infections, and tumors which are rare in people who have normal immune function. These late symptoms of infection are referred to as acquired immunodeficiency syndrome (AIDS). This stage is often also associated with unintended weight loss.

<span class="mw-page-title-main">Seth Berkley</span> American medical epidemiologist

Seth Franklin Berkley is an American medical epidemiologist and a global advocate of the power of vaccines. He is the founder and former president and CEO of the International AIDS Vaccine Initiative (IAVI) and former CEO of Gavi, the Vaccine Alliance. He is currently a senior advisor to the Pandemic Center at Brown University School of Public Health.

<span class="mw-page-title-main">Alimuddin Zumla</span> British-Zambian physician

Sir Alimuddin Zumla,, FRCP, FRCPath, FRSB is a British-Zambian professor of infectious diseases and international health at University College London Medical School. He specialises in infectious and tropical diseases, clinical immunology, and internal medicine, with a special interest in HIV/AIDS, respiratory infections, and diseases of poverty. He is known for his leadership of infectious/tropical diseases research and capacity development activities. He was awarded a Knighthood in the 2017 Queens Birthday Honours list for services to public health and protection from infectious disease. In 2012, he was awarded Zambia's highest civilian honour, the Order of the Grand Commander of Distinguished services - First Division. In 2022, for the fifth consecutive year, Zumla was recognised by Clarivate Analytics, Web of Science as one of the world's top 1% most cited researchers. In 2021 Sir Zumla was elected as Fellow of The World Academy of Sciences.

Stephen S. Morse is an American epidemiologist, influenza researcher and specialist on emerging infectious diseases, who has served as an adviser on the epidemiology of infectious diseases and on improving disease early warning systems to numerous government and international organizations. As of 2016, he is Professor of Epidemiology at the Mailman School of Public Health of Columbia University. His seminal book Emerging Viruses (1993) was selected by American Scientist for its list of "100 Top Science Books of the 20th Century".

The United States Intelligence Community (IC) has a long history of producing assessments on infectious diseases. Most of these papers are distributed to government administrators and inform the choices of policymakers. Three of these assessments stand out as analytical products that have had important impact on the awareness, funding and treatment of infectious diseases around the world. The first paper is the National Intelligence Estimate on the Global Infectious Disease Threat, the second paper is the assessment on the Next Wave of HIV/AIDS, and the third paper was the assessment on SARS. This page summarizes the findings of these three papers and provides information about their impact.

<span class="mw-page-title-main">Ira Longini</span> American biostatistician

Ira M. Longini is an American biostatistician and infectious disease epidemiologist.

Dame Anne Mandall Johnson DBE FMedSci is a British epidemiologist, known for her work in public health, especially the areas of HIV, sexually transmitted infections and infectious diseases.

Kelly J. Henning is an epidemiologist and medical doctor currently leading the public health program of Bloomberg Philanthropies. She has led the program since it began in 2007. She was the first person to serve as director of epidemiology for the New York City Department of Health and Mental Hygiene. Henning said of working in public health "I have the opportunity to help improve the health and lives of millions of people. That's what really speaks to me."

<span class="mw-page-title-main">Gerald T. Keusch</span> American physician-scientist

Gerald T. Keusch is an American physician-scientist and academic administrator. Keusch is the associate provost for global health at Boston University Medical Campus and a professor of international health and medicine at Boston University School of Public Health. He was the director of John E. Fogarty International Center and the associate director of international research at the National Institutes of Health from 1998 to 2003.

Daniel R. Lucey is an American physician, researcher, senior scholar and adjunct professor of infectious diseases at Georgetown University, and a research associate in anthropology at the Smithsonian National Museum of Natural History, where he has co-organised an exhibition on eight viral outbreaks.

<span class="mw-page-title-main">Adaora Adimora</span> Professor of Medicine and epidemiology

Adaora Alise Adimora is an American doctor and academic. She is the Sarah Graham Kenan Distinguished Professor of Medicine and professor of epidemiology at the University of North Carolina School of Medicine. Her research centers on the transmission of HIV, as well as other sexually transmitted infections (STIs), among minority populations. Her work has highlighted the importance of social determinants of HIV transmission and the need for structural interventions to reduce risk. In 2019, she became an elected member of the National Academy of Medicine in recognition of her contributions.

Sten H. Vermund is the Anna M.R. Lauder Professor of Public Health, and former Dean (2017-2022) of the Yale School of Public Health, and also serves as a Professor in Pediatrics at the Yale School of Medicine. He is a pediatrician and infectious disease epidemiologist focused on diseases of low and middle-income countries.

Gypsyamber D'Souza is an American epidemiologist. She is a professor of epidemiology at the Johns Hopkins Bloomberg School of Public Health. D'Souza researches infectious diseases, cancer prevention, and translational epidemiology. She is a principal investigator of the Multicenter AIDS Cohort Study / Women's Interagency HIV Study Combined Cohort Study (Mwccs.org).

References

  1. 1 2 3 4 "Ann Marie Kimball".
  2. 1 2 "Dr Ann Marie Kimball".
  3. ↑ "Ann Marie Kimball".
  4. ↑ "Swine flu tests response plans". 10 May 2009.
  5. ↑ Gunn, R. A.; Kimball, A. M.; Pollard, R. A.; Feeley, J. C.; Feldman, R. A.; Dutta, S. R.; Matthew, P. P.; Mahmood, R. A.; Levine, M. M. (1979). "Bottle feeding as a risk factor for cholera in infants". Lancet. 2 (8145): 730–732. doi:10.1016/s0140-6736(79)90653-6. PMID   90813. S2CID   1584818.
  6. ↑ "Rotary Covid-19 Task Force Update".
  7. ↑ "APEC Emerging Infectious Disease Network (EINET): Expert Roundtable Series on Hot Topics in Emerging Infectious Diseases" (PDF).
  8. ↑ "Health Working Group".
  9. ↑ Paye, M. F.; Gamougame, K.; Payamps, S. K.; Feagins, A. R.; Moto, D. D.; Moyengar, R.; Naïbeï, N.; Vuong, J.; Diallo, A. O.; Tate, A.; Soeters, H. M.; Wang, X.; Acyl, M. A. (2019). "Implementation of Case-Based Surveillance and Real-time Polymerase Chain Reaction to Monitor Bacterial Meningitis Pathogens in Chad". The Journal of Infectious Diseases. 220 (Suppl 4): S182–S189. doi:10.1093/infdis/jiz366. PMC   6822964 . PMID   31671450.
  10. ↑ Kimball, A. M. (2016). "Emergence of Novel Human Infections: New Insights and New Challenges". International Encyclopedia of Public Health: 448–454. doi:10.1016/B978-0-12-803678-5.00153-3. ISBN   9780128037089. PMC   7158573 .
  11. ↑ Kimball, Ann Marie; Harper, David; Creamer, Kellie; Adeyemi, Ade; Yates, Robert; Lillywhite, Louis; Told, Michaela; Heymann, David L. (August 2019). "Strengthening Public Health Leadership in Africa: An Innovative Fellowship Program". Academic Medicine. 94 (8): 1146–1149. doi: 10.1097/ACM.0000000000002707 . PMID   30870155. S2CID   78091921.
  12. ↑ Blas, M. M.; Alva, I. E.; Cabello, R.; Garcia, P. J.; Carcamo, C.; Redmon, M.; Kimball, A. M.; Ryan, R.; Kurth, A. E. (2007). "Internet as a tool to access high-risk men who have sex with men from a resource-constrained setting: a study from Peru". Sexually Transmitted Infections. 83 (7): 567–570. doi:10.1136/sti.2007.027276. PMC   2598637 . PMID   17932128.
  13. ↑ Kimball, A. M.; Wong, K. Y.; Taneda, K. (2005). "An evidence base for International Health Regulations: quantitative measurement of the impacts of epidemic disease on international trade". Revue Scientifique et Technique (International Office of Epizootics). 24 (3): 825–832. PMID   16642753.
  14. ↑ "COVID-19 and the Spanish Flu - Drawing Comparisons".
  15. ↑ "Rotary Program 4-1-20 Dr. Ann Marie Kimball, An Epidemiologist's Perspective on the Coronavirus". YouTube .
  16. ↑ "America's COVID death toll tops 675,000, equaling the total from the 1918-19 flu". 20 September 2021.
  17. ↑ "Covid has now killed about as many Americans as the Spanish Flu". NBC News .
  18. ↑ Bahl, M. R. (January 2007). "Book Review: Risky Trade: Infectious Disease in the Era of Global Trade by M R Bahl". Journal of the Royal Society for the Promotion of Health. 127 (1): 47–48. doi:10.1177/146642400712700111. S2CID   72450248.
  19. ↑ Chorev, Nitsan (2007). "Risky Trade: Infectious Disease in the Era of Global Trade (review)Nitsan Chorev". The Canadian Journal of Sociology. 32 (4): 513–515. doi:10.2307/20460671. JSTOR   20460671. S2CID   142728270.
  20. ↑ Torner, N. (2007). "Risky trade. Infectious disease in the era of global trade". Journal of Epidemiology and Community Health. 61 (10): 926. doi:10.1136/jech.2007.059659. PMC   2652973 .
  21. ↑ Price-Smith, A. (2008). "Risky Trade: Infectious Disease in the Era of Global Trade". Emerging Infectious Diseases. 14 (10): 1678–1679. doi:10.3201/eid1410.080835. PMC   2609866 .
  22. ↑ "SEARCH FELLOWS". Archived from the original on 2019-03-22. Retrieved 2022-01-05.
  23. ↑ "Emerging Health Threats Journal" (PDF).
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.